期刊文献+

Ⅱ型胶原-透明质酸构建组织工程软骨复合三维纳米支架的体外实验研究 被引量:9

EXPERIMENTAL STUDY ON TISSUE ENGINEERED CARTILAGE COMPLEX THREE-DIMENSIONAL NANOSCAFFOLD WITH COLLAGEN TYPE Ⅱ AND HYALURONIC ACID IN VITRO
原文传递
导出
摘要 目的探讨Ⅱ型胶原-透明质酸(hyaluronic acid,HA)构建软骨组织工程复合三维纳米支架的可行性。 方法将Ⅱ型胶原和HA以8∶1(W∶W)比例溶于三氟乙醇和水按1∶1(V∶V)比例混合的溶剂中制成溶液,通过静电纺丝技术制备三维多孔纳米支架材料,通过光镜和扫描电镜观察其表面形貌,测定其孔隙率、吸水率、表面接触角和降解率。取1周龄日本大耳兔肋软骨,采用酶消化法制备软骨细胞。取第2代软骨细胞种植于支架上,用细胞计数试剂盒8(cell counting kit 8,CCK-8)评价其细胞黏附性及增殖情况;细胞-支架复合物体外连续培养2周后,行组织学和免疫组织化学染色观察其生物学形态及细胞外基质(extracellular matrix,ECM)分泌情况。 结果以最佳电纺液浓度为10%、接收距离为10 cm、纺丝注射速度为5 mL/h电纺获得的支架材料,光镜及扫描电镜观察示其孔隙均匀,纳米纤维直径均匀(300~600 nm),孔隙率为89.5% ± 25.0%,表面接触角为(35.6 ± 3.4)°,24 h内支架吸水率可达1 120% ± 34%,48 d内支架降解率可达42.24% ± 1.51%。CCK-8检测结果显示,培养12 h细胞在支架上黏附率可达169.14% ± 11.26%,培养7 d时细胞存活率可达126.03% ± 4.54%。组织学和免疫组织化学染色示,细胞在支架上黏附增殖情况良好,可分泌ECM;细胞在支架上培养2周后,有类似于软骨陷窝的结构形成。 结论以Ⅱ型胶原-HA制备的复合三维纳米支架材料具有良好的物理性能、生物学性能和促进细胞黏附及增殖的能力,是一种良好的组织工程软骨支架材 料。 ObjectiveTo explore the possibility of constructing tissue engineered cartilage complex three-dimensional nano-scaffold with collagen type II and hyaluronic acid (HA) by electrospinning. MethodsThe three-dimensional porous nano-scaffolds were prepared by electrospinning techniques with collagen type II and HA (8∶1, W∶W), which was dissolved in mixed solvent of 3-trifluoroethanol and water (1∶1, V∶V). The morphology were observed by light microscope and scanning electron microscope (SEM). And the porosity, water absorption rate, contact angle, and degradation rate were detected. Chondrocytes were harvested from 1-week-old Japanese white rabbit, which was disgested by 0.25% trypsin 30 minutes and 1% collagenase overlight. The passage 2 chondrocytes were seeded on the nano-scaffold. The cell adhesion and proliferation were evaluated by cell counting kit 8 (CCK-8). The cell-scaffold composites were cultured for 2 weeks in vitro, and the biological morphology and extracelluar matrix (ECM) secretion were observed by histological analysis. ResultsThe optimal electrospinning condition of nano-scaffold was 10% electrospinning solution concentration, 10 cm receiver distance, 5 mL/ h spinning injection speed. The scaffold had uniform diameter and good porosity through the light microscope and SEM. The diameter was 300-600 nm, and the porosity was 89.5% ± 25.0%. The contact angle was (35.6 ± 3.4)°, and the water absorption was 1 120% ± 34% at 24 hours, which indicated excellent hydrophilicity. The degradation rate was 42.24% ± 1.51% at 48 days. CCK-8 results showed that the adhesive rate of cells with scaffold was 169.14% ± 11.26% at 12 hours, and the cell survival rate was 126.03% ± 4.54% at 7 days. The histological and immunohistochemical staining results showed that the chondrocytes could grow well on the scaffold and secreted ECM. And the similar cartilage lacuma structure could be found at 2 weeks after co-culture, which suggested that hyaline cartilage formed. ConclusionThe collage type II and HA complex three-dimensional nano-scaffold has good physicochemical properties and excellent biocompatibility, so it can be used as a tissue engineered cartilage scaffold.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2013年第10期1240-1245,共6页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目(81171472、81201407) 四川省教育厅创新团队资助项目(13TD0030)~~
关键词 组织工程软骨 复合三维纳米支架 静电纺丝 Ⅱ型胶原 透明质酸 Tissue engineered cartilage Complex three-dimensional nano-scaffold Electrospinning Collagen type II Hyaluronic acid
  • 相关文献

参考文献24

  • 1邹阿鹏,宋振,兰忠煜,白希壮.关节软骨的缺损与修复[J].中国组织工程研究与临床康复,2010,14(37):6991-6994. 被引量:15
  • 2窦晓丽,段晓琴,夏玲,袁望舒,曲福玲,罗媛媛,刘忠良.骨关节炎:关节软骨退变的相关研究与进展[J].中国组织工程研究与临床康复,2011,15(20):3763-3766. 被引量:53
  • 3Zhang Q, Yao K, Liu L, et al. Evaluation of porous collagen membrane in guided tissue regeneration. Artificial Cell Blood Substit Immobil Biotechnol, 1999, 27(3): 245-253.
  • 4Solchaga LA, Temenoff JS, Gao J, et al. Repair of osteochondral defects with hyaluronan and polyester-based scaffolds. Osteoarthritis Carti- lage, 2005, 13(4): 279-309.
  • 5Jeon YH, Choi JH, Sung JK, et al. Different effects of PLGA and chito- san scaffolds on human cartilage tissue engineering. J Craniofac Surg, 2007, 18(6): 1249-1258.
  • 6Wang Y, Bian YZ, Wu Q, et al. Evaluation of three-dimensional scaf- folds prepared from poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) for growth of allogeneic chondrocytes for cartilage repair in rabbits. Biomaterials, 2008, 29(19): 2858-2868.
  • 7Li WJ, Richard T, Chukwuka O, et al. A three-dimensional nanofi- brons scaffold for cartilage tissue engineering using human mesenchy- mal stem cells. Biomaterials, 2005, 26(6): 599-609.
  • 8Liao J, Guo X, Grande-Allen KJ, et al. Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for carti- lage tissue engineering. Biomaterials, 2010, 31(34): 8911-8920.
  • 9Chung C, Burdick JA. Engineering cartilage tissue. Adv Drug Deliv Rev, 2008, 60(2): 243-262.
  • 10Laurens E, Schneider E, Winalski CS, et al. A synthetic cartilage extra- cellular matrix model: hyaluronan and collagen hydrogel relaxivity, impact of macromolecular concentration on dGEMRIC. Skeletal Ra- diol, 2012, 41(2): 209-217.

二级参考文献57

  • 1王京生,裴福兴.骨关节炎生物学标志物研究进展[J].华西医学,2008,23(5):1219-1221. 被引量:1
  • 2王翠民,谷宁飞,张淑贞.骨关节炎生物学标志物研究进展[J].中国病案,2009,10(3):42-44. 被引量:2
  • 3李蕊,肖迪,周军.骨性关节炎软骨生物学标志物的国外研究进展[J].中国康复医学杂志,2007,22(5):475-477. 被引量:10
  • 4朱爱萍 吴钧 张娜 等.壳聚糖--一种具有应用潜力的组织工程支架材料.化学通报,2002,65:1-5.
  • 5Burnett BP,Levy R,Cole BJ.Metabolic mechanisms in the pathogenesis of osteoarthritis.J Knee Surg.2006;19(3):191-197.
  • 6Stove J,Gremmes C,Gunther KP,et al.Metabolic activity and gene expression of osteoarthritic chondrocytes in correlation with radiological and histological characteristics.Biomed Pharmacother.2006;60(10):644-647.
  • 7Koike T.Destruction of articular cartilage.Clin Calcium.2006; 16(9):1543-1547.
  • 8Takahashi M,Naito K,Abe M,et al.Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis.Arthritis Res Ther.2004;6(3):208-212.
  • 9Bigg,Heather F,Rowan AD.The inhibition of metalloproteinasesas a therapeutic target in rheumatoid arthritis and osteoarthritis.Currio in Pharm.2001;1(3):314-320.
  • 10Karatas F,Ozatesi,Canatan H,et al.Antioxidant status&lipid peroxidation in patients with rheumatoid arthritis.Indian J Med Res.2003;118(1):178-181.

共引文献71

同被引文献101

引证文献9

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部